EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts

Jie Yang, Yuting Huang, Zhimin Cui, Chang Liu, Guofang Xie

Allergologia et Immunopathologia · 2024

DOI: 10.15586/aei.v52i4.1111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2024. Verfasst von Jie Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, ChaoHu Hospital of Anhui Medical University, Hefei City, Anhui Province, China. Hauptthemen laut MEDLINE: Cell Proliferation, Berberine, Myofibroblasts, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary fibrosis (PF) is a chronic, progressive, and irreversible heterogeneous disease of lung interstitial tissue. To combat progression of PF, new drugs are required to be developed. Rhizoma coptidis (COP), one of the main alkaloids of Coptis chinensis, is a traditional herbal medicine used to treat various inflammatory diseases.

Objective

To investigate the possible effects of Coptisine (Cop) on the growth, inflammation, as well as FMT of TNF-β1-induced HFL1 cells and uncover the mechanism. Material and Methods: Human fetal lung fibroblast 1 (HFL1) was induced using 6ng/mL TGF-β1 as a model of pulmonary fibrosis. CCK-8, Brdu, and transwell assays indicated the effects on cell growth as well as motility. qPCR and the corresponding kits indicted the effects on cell inflammation. Immunoblot showed the effects on FMT and further confirmed the mechanism.

Results

Coptisine inhibits excessive growth as well as motility of TNF-β1-induced HFL1 cells. It further inhibits inflammation and ROS levels in TNF-β1-induced HFL1 cells. Coptisine inhibits the FMT process of TNF-β1-induced HFL1 cells. Mechanically, coptisine promotes the Nrf2/HO-1 pathway.

Conclusion

Coptisine can inhibit the excessive growth, inflammation as well as FMT of lung fibroblasts into myofibroblasts. It could serve as a promising drug of PF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationBerberineMyofibroblastsLungFibroblastsHumansInflammationNF-E2-Related Factor 2Pulmonary FibrosisTransforming Growth Factor beta1Cell LineCoptisHeme Oxygenase-1Signal TransductionCell MovementReactive Oxygen SpeciesCell DifferentiationAnti-Inflammatory Agents

Stichwörter der Autor:innen

FMTNrf2/HO-1 pathwayRhizoma coptidis (COP)inflammationpulmonary fibrosis (PF)

Substanzen

BerberinecoptisineNF-E2-Related Factor 2Transforming Growth Factor beta1Heme Oxygenase-1NFE2L2 protein, humanHMOX1 protein, humanReactive Oxygen SpeciesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Geriatrics, ChaoHu Hospital of Anhui Medical University, Hefei City, Anhui Province, China.
  • Department of Radiotherapy, ChaoHu Hospital of Anhui Medical University, Hefei City, Anhui Province, China; yth_0417@163.com.

Zitieren

APA

Yang, J., Huang, Y., Cui, Z., Liu, C., & Xie, G. (2024). Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v52i4.1111

Vancouver

Yang J, Huang Y, Cui Z, Liu C, Xie G. Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts. Allergologia et Immunopathologia. 2024. doi:10.15586/aei.v52i4.1111

BibTeX
@article{Yang2024,
  author = {Yang, Jie and Huang, Yuting and Cui, Zhimin and Liu, Chang and Xie, Guofang},
  title = {Rhizoma coptidis can inhibit the excessive proliferation, inflammation, and transformation of lung fibroblasts into myofibroblasts},
  journal = {Allergologia et Immunopathologia},
  year = {2024},
  doi = {10.15586/aei.v52i4.1111}
}
Kostenlos starten →